JUSTINE BOLLINGER: Open Payments
NPI 1306433602 · STANTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 64 payments from 13 companies in 2025. Trend: 2023 $595 · 2024 $1,034 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $243 |
| AstraZeneca Pharmaceuticals LP | 11 | $214 |
| Otsuka America Pharmaceutical, Inc. | 11 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $156 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Eisai Inc. | 3 | $65 |
| Lilly USA, LLC | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Exact Sciences Corporation | 3 | $51 |
| Lundbeck LLC | 2 | $51 |
Products named: REXULTI, AIRSUPRA, CAPLYTA, Wegovy, Rybelsus, Leqembi, MOUNJARO, JARDIANCE.
Industry payments across MI — which companies pay providers there.
